Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563]

Authors

Institutions

Publication Details

Journal
Heliyon
Published
2025-11-01
DOI
https://doi.org/10.1016/j.heliyon.2025.e44134
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563]

Jiahui Shao, Feng Zhao, H. Liu, Binbin Li et al.
Heliyon
Alzheimer's disease research and treatments
article

Retraction notice to "Novel fabrication of Cu(II)-incorporated chiral d-penicillamine-chitosan nanocomposites enantio-selectively inhibit the induced amyloid β aggregation for Alzheimer's disease therapy" [Heliyon 10 (2024) e23563]

Jiahui Shao, Feng Zhao, H. Liu, Binbin Li, Pingling Wu, Heming Yu, Zehong Gao, Hui Yang
article en

Abstract

No abstract available for this paper.
HeliyonVol. 11(16)
Nanjing University of Chinese Medicine (CN), Wenzhou Medical University (CN), The First People's Hospital of Wenling (CN)
Openalex Percentile: Top 58%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.